Study of the Impact of Intermittent Preventive Treatment in Schools on Malaria, Anaemia and Education.

NCT00142246 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

6758

Enrollment

OTHER

Sponsor class

Conditions

Malaria, Falciparum

Interventions

DRUG: Intermittent preventive treatment (SP and amodiaquine)
OTHER: Placebo

Sponsor

London School of Hygiene and Tropical Medicine

Collaborators

[object Object]